Modulation of renin angiotensin system predominantly alters sclerotic phenotype of glomeruli in HIVAN

Histology and Histopathology

Volumn 29, Issue 12, 2014, Pages 1575-1581

  Plagov, Andrei ^a   Lan, Xiqian ^a   Rai, Partab ^a   Kumar, Dileep ^a   Lederman, Rivka ^a   Rehman, Shabina ^a   Malhotra, Ashwani ^a   Ding, Guohua ^a   Chander, Praveen N ^b   Singhal, Pravin C ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Angiotensinogen; Focal Glomerulosclerosis; HIV associated Nephropathy; Renin angiotensin system

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL; DISEASE MODEL; FOCAL GLOMERULOSCLEROSIS; GENETICS; IMMUNOHISTOCHEMISTRY; MOUSE; PATHOLOGY; PHENOTYPE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRANSGENIC MOUSE; VIROLOGY;

AIDS-ASSOCIATED NEPHROPATHY; ANIMALS; DISEASE MODELS, ANIMAL; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; PHENOTYPE; RENIN-ANGIOTENSIN SYSTEM;

EID: 84912527105     PISSN: 02133911     EISSN: 16995848     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Atta M.G. (2010). Diagnosis and natural history of HIV-associated nephropathy. Adv. Chronic Kidney Dis. 17, 52-58
2. Barisoni L. and Kopp J.B. (2002). Modulation of podocyte phenotype in collapsing glomerulopathies. Microsc. Res. Tech. 57, 254- 262.
3. Berliner A.R., Fine D.M., Lucas G.M., Rahman M.H., Racusen L.C., Scheel P.J. and Atta M.G. (2008). Observations on a cohort of HIVinfected patients undergoing native renal biopsy. Am. J. Nephrol. 28, 478-486.
4. Bird J.E., Durham S.K., Giancarli M.R., Gitliz P.H., Pandya D.G., Dambach D.M., Mozes M.M. and Kopp B. (1989). Captopril prevents nephropathy in HIV-transgenic mice. J Am. Soc. Nephrol. 9, 1441- 1447.
5. Bourgoignie J.J. and Pardo V. (1991). The nephropathology in human immunodeficiencyvirus (HIV-1) infection. Kidney Int. 40 (suppl), S19- S23.
6. Burns C., Paul S.K. Toth I.R. and Siva L. (1999). Effect of angiotensinconverting enzyme inhibition in HIV-associated nephropathy. J. Am. Soc. Nephrol. 8, 1140-1146.
7. Cantor E.S., Kimmel P.L. and Bosch J.P. (1991). Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy. Arch. Intern. Med. 151, 125-128.
8. Chan K.T., Papeta N., Martino J., Zheng Z., Frankel R.Z., Klotman P.E., D'Agati V.D. Lifton R.P and Gharavi A.G. (2009). Accelerated development of collapsing glomerulopathyin mice congenic for the HIVAN1 locus. Kidney Int. 75, 366-372.
9. D'Agati V. (2003). Pathologic classification of focal segmental glomerulosclerosis. Semin. Nephrol. 23, 117-134.
10. Dijkman H., Smeets B., van der Laak J., Steenbergen E. and Wetzels J. (2005). The parietal epithelial cell is crucially involved in human idiopathic focal segmental glomerulosclerosis. Kidney Int. 68, 1562- 1572.
11. Dijkman H.B., Weening J.J., Smeets B., Verrijp K.C., van Kuppevelt T.H., Assmann K.K., Steenbergen E.J. and Wetzels J.F. (2006). Proliferating cells in HIV and pamidronate-associated collapsing focal segmental glomerulosclerosis are parietal epithelial cells. Kidney Int. 70, 338-344.
12. Ding G., Kapasi A.A., Franki N., Gibbons N., Kasinath B.S. and Singhal P.C. (2002). Angiotensin II induces glomerular epithelial cell apoptosis. Am. J. Physiol. 283, F173-F180.
13. Egido J. (1996). Vasoactive hormones and renal sclerosis. Kidney Int. 49, 578-598.
14. Fogo A.B. (2003). Approach to renal biopsy. Am. J. Kidney Dis. 42, 826- 836.
15. Freedman B.I., Kopp J.B., Langefeld C.D., Genovese G., Friedman D.J., Nelson G.W., Winkler C.A., Bowden D.W. and Pollak M.R. (2010). The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.. J. Am. Soc. Nephrol. 21, 1422-1426.
16. Friedman E.A. and Tao T.K. (1995). Disappearance of uremia due to heroin-associated nephropathy. Am. J. Kidney Dis. 25, 689-689.
17. Fuiano G., Comi N., Magri P., Sepe V., Balletta M.M., Esposito C., Uccello F., Dal Canton A. and Conte G. (1996). Serial morphometric analysis of sclerotic lesion ns in primary "focal" segmental glomerulosclerosis. Am. Soc. Nephrol. 7, 49-55.
18. Gharavi A.G., Ahmad T., Wong R.D., Hooshyar R., Vaughn J., Oller S., Frankel R.Z., Bruggeman L.A., D'Agati V.D., Klotman P.E. and Lifton R.P. (2004). Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3. Proc. Natl. Acad. Sci. USA 101, 2488-2489.
19. Howie A.J., Ferreira M.A.S. and Adu D. (2001). Prognostic value of simple measurement of chronic damage in renal biopsy specimens. Nephrol. Dial. Transplant. 16, 1163-1169.
20. Hoy W.E., Samuel T., Hughson M.D., Nicol J.L. and Bertram J.F. (2006). How many glomerular profiles must be measured to obtain reliable estimates of mean glomerular areas in human renal biopsies? J. Am. Soc. Nephrol. 17, 556-563.
21. Hughson M.D., Johnson K., Young R.J., Hoy W.E. and Bertram J.F. (2002). Glomerular size and glomerulosclerosis: relationships to disease categories, glomerular solidification, and ischemic obsolescence. Am. J. Kidney Dis. 39, 679-688.
22. Ideura H., Hiromura K., Hiramatsu N., Shigehara T., Takeuchi S., Tomioka M., Sakairi T., Yamashita S., Maeshima A., Kaneko Y., Kuroiwa T., Kopp J.B. and Nojima Y. (2007). Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy. Am. J. Physiol. Renal. Physiol. 293, F1214-1221.
23. Jia J., Ding G., Zhu J., Chen C., Liang W., Franki N. and Singhal P.C. (2008). Angiotensin II infusion induces nephrin expression changes and podocyte apoptosis. Am. J. Nephrol. 28, 500-507
24. Kimmel P.L., Barisoni L. and Kopp J.B. (2003). Pathogenesis and treatment of HIV- associated renal diseases: lessons from clinical and animal studies, molecular pathologic correlations, and genetic investigations. Ann. Intern. Med. 139, 214-226.
25. Kopp J.B., Klotman M.E., Adler S.H., Bruggeman L.A., Dickie P., Marinos N.J., Eckhaus M., Bryant J.L., Notkins A.L. and Klotman P.E (1992). Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc. Natl. Acad. Sci. USA 89, 1577-1581.
26. Kumar D., Salhan D., Magoon S., Torri D.D., Sayeneni S., Sagar A., Bandhlish A., Malhotra A., Chander P.N. and Singhal P.C. (2011). Adverse host factors exacerbate occult HIV-associated nephropathy. Am. J. Pathol. 179, 1681-92.
27. Kumar D., Plagov A,. Yadav I., Torri D.D., Sayeneni S., Sagar A., Rai P., Adabala M., Lederman R., Chandel N., Ding G., Malhotra A. and Singhal P.C. (2012). Inhibition of Renin Activity Slows down the Progression of HIVAN. Am. J. Physiol. Renal. Physiol. 303, F711- 220.
28. Lu T.C., He J.C. and Klotman P. (2006). Animal models of HIVassociated nephropathy. Curr. Opin. Nephrol.Hypertens. 15, 233- 237.
29. Matsusaka T., Hymes J. and Ichikawa I. (1996). Angiotensin in progressive renal diseases: Theory and practice. J. Am. Soc. Nephrol. 7, 2025-2043.
30. Möller C.C., Pollak M.R. and Reiser (2006). The genetic basis of human glomerular disease. J. Adv. Chronic Kidney Dis. 13, 166-173.
31. Pardo V., Aldana M., Colton R.M., Fischl M.A., Jaffe D., Moskowitz L., Hensley G.T. and Bourgoignie J.J. (1984). Glomerular lesions in acquired immunodeficiency syndrome. Ann. Intern. Med. 101, 429- 434.
32. Post F.A., Campbell L.J., Hamzah L., Collins L., Jones R., Siwani R., Johnson L., Fisher M., Holt S.G., Bhagani S., Frankel A.H., Wilkins E., Ainsworth J.G., Larbalestier N., Macallan D.C., Banerjee D., Baily G., Thuraisingham R.C., Donohoe P., Hendry B.M., Hilton R.M., Edwards S.G., Hangartner R., Howie A.J., Connolly J.O. and Easterbrook P.J. (2008). Predictors of renal outcome in HIVassociated nephropathy. Clin. Infect Dis. 46, 1282-1289.
33. Rao T.K.S., Filppone E.J., Nicastri A.D., Landesman S.H., Frank E., Chen C.K. and Friedman E.A. (1984). Associated focal segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N. Engl. J. Med. 310, 664-673.
34. Salhan D., Husain M., Subrati A., Goyal R., Singh T., Rai P., Malhotra A. and Singhal P.C. (2012). HIV-induced kidney cell injury: role of ROS-induced downregulated vitamin D receptor. Am. J. Physiol. Renal Physiol. 303, F503-514.
35. Szczech L.A., Gupta S.K., Habash R., Guasch A., Kalayjian R., Appel R., FieldsT.A., Svetkey L.P., Flanagan K.H., Klotman P.E. and Winston J.A. (2004). The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int. 66, 1145-1152.
36. Valeri A., Barisoni L., Appel G.B., Seigle R., D'Agati V. (1996). Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study. Kidney Int. 50, 1734-1746.
37. Weiss M.A., Daquioag E., Margolin E.G. and Pollak V.E. (1986). Nephrotic syndrome, progressive irreversible renal failure, and glomerular "collapse": a new clinicopathologic entity? Am. J. Kidney Dis. 7, 20-28.
38. Yadav A., Vallabu S., Arora S., Tandon P., Slahan D., Teichberg S. and Singhal P.C. (2010a). ANG II promotes autophagy in podocytes. Am. J. Physiol. Cell. Physiol. 299, C488-C4896
39. Yadav A., Vallabu S., Kumar D., Ding G., Charney D.N., Chander P.N. and Singhal P.C. (2010b). HIVAN phenotype: consequence of epithelial mesenchymal transdifferentiation. Am. J. Physiol. Renal Physiol. 298, F734-F44.
40. Young R.J., Hoy W.E., Kincaid-Smith P., Seymour A.E. and Bertram J.F. (2000). Glomerular size and glomerulosclerosis in Australian aborigines. Am. J. Kidney Dis. 36, 481-489.